4D PHARMA PLC

Oxford Finance Luxembourg Sàrl (Acting in Respect of Its Compartment 4) as Collateral Agent

1. patents.. Family: 17; priority date: 4 march 2016; filing date: 6 march 2017; territory: europe; application no.: 17709911.6; publication no.: 3313423; patent no.: 3313423; status: granted, validated in the united kingdom; current expiry: 6 march 2037; summary of coverage: blautix in the treatment of visceral hypersensitivity; proprietor: 4D pharma PLC.. For further details of the patents subject to this charge please see part 1 of schedule 4 (registered intellectual property) of the charge.. 2. trademarks.. Family: 4; mark: thetanix; classes: 1, 5; territory: united kingdom; priority date: 12 november 2013; filing date: 12 november 2013; application no.: 3101576; registration no.: UK00003101576; status: registered.. For further details of the trademarks subject to this charge please see part 1 of schedule 4 (registered intellectual property) of the charge.

Oxford Finance Luxembourg Sàrl (Acting in Respect of Its Compartment 4) as Collateral Agent

1. patents.. Title: blautia hydrogenotrophica in the treatment of gastrointestinal disorders, including ibs; application number: 01934089.2; application date: 11-may-01; application status: granted, validated in the united kingdom; patent number: 1280541; territory: europe; patent date:11-may-00.. For further details of the patents subject to this charge please see exhibit b of the charge.. 1. trademarks.. Family: 4; mark: thetanix; territory: united kingdom; filing date: 12 november 2013; application number: 3101576; registration number: 3101576; registration date: 12 november 2013; status: registered.. For further details of the trademarks subject to this charge please see exhibit c of the charge.

Oxford Finance Luxembourg Sàrl (Acting in Respect of Its Compartment 4) as Collateral Agent

N/A.